Hae Yoon Choi Selected Research

Hae Yoon Choi Research Topics

Disease

17	Insulin Resistance 02/2017 - 11/2011
13	Inflammation (Inflammations) 01/2015 - 03/2011
11	Obesity 10/2014 - 04/2011
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2015 - 11/2012
7	Type 2 Diabetes Mellitus (MODY) 01/2014 - 11/2011
6	Atherosclerosis 09/2013 - 03/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 07/2014 - 11/2011
3	Non-alcoholic Fatty Liver Disease 02/2017 - 02/2013
1	Sarcopenia 08/2014
1	Stable Angina 01/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014
1	Acute Coronary Syndrome 01/2014
1	Overweight 09/2013
1	Atherosclerotic Plaque (Atheroma) 03/2013
1	Abdominal Obesity 02/2013
1	Glucose Intolerance 01/2013
1	Prediabetic State (Prediabetes) 11/2012
1	Body Weight (Weight, Body) 10/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2012
1	Prehypertension 08/2011

Drug/Important Bio-Agent (IBA)

11	C-Reactive ProteinIBA 02/2015 - 11/2011
8	AdipokinesIBA 10/2014 - 04/2011
7	AdiponectinIBA 01/2014 - 03/2011
6	Glucose (Dextrose)FDA LinkGeneric 02/2017 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2012
4	HDL CholesterolIBA 02/2017 - 08/2011
3	LDL CholesterolIBA 01/2015 - 11/2011
3	Selenoprotein PIBA 01/2014 - 01/2013
3	ProgranulinsIBA 01/2014 - 01/2013
3	Vitamin D FDA LinkGeneric 01/2014 - 04/2013
2	Triglycerides (Triacylglycerol)IBA 02/2017 - 01/2015
2	alpha-2-HS-GlycoproteinIBA 10/2013 - 09/2013
2	LeptinIBA 09/2013 - 03/2011
2	Messenger RNA (mRNA)IBA 09/2013 - 01/2013
2	ApolipoproteinsIBA 09/2013 - 10/2012
2	Biomarkers (Surrogate Marker)IBA 02/2013 - 04/2011
2	Receptor for Advanced Glycation End ProductsIBA 10/2012 - 02/2012
1	CreatinineIBA 02/2017
1	Monoamine Oxidase (MAO)IBA 03/2015
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2014
1	Lipocalin-2IBA 10/2014
1	MyokinesIBA 08/2014
1	P 569IBA 08/2014
1	TunicamycinIBA 07/2014
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 07/2014
1	LC15-0444IBA 07/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2014
1	Insulin (Novolin)FDA Link 06/2014
1	Indicators and Reagents (Reagents)IBA 05/2014
1	Adenosine Monophosphate (AMP)IBA 01/2014
1	Toll-Like Receptor 4IBA 01/2014
1	CarrageenanIBA 01/2014
1	4-phenylbutylamineIBA 01/2014
1	Protein Kinases (Protein Kinase)IBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013
1	EnzymesIBA 09/2013
1	LipidsIBA 09/2013
1	hydroxide ionIBA 04/2013
1	25-hydroxyvitamin DIBA 04/2013
1	salicylsalicylic acid (salsalate)IBA 01/2013
1	SalicylatesIBA 01/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2013
1	PalmitatesIBA 01/2013
1	AntioxidantsIBA 11/2012
1	pigment epithelium-derived factorIBA 11/2012
1	Nonesterified Fatty Acids (NEFA)IBA 10/2012
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2012
1	Pharmaceutical PreparationsIBA 04/2012
1	Eplerenone (Inspra)FDA LinkGeneric 04/2012
1	Mineralocorticoid Receptor AntagonistsIBA 04/2012
1	Lisinopril (Prinivil)FDA LinkGeneric 04/2012
1	AldosteroneIBA 04/2012
1	LigandsIBA 02/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2011
1	Angiotensin Receptor AntagonistsIBA 11/2011
1	Blood Glucose (Blood Sugar)IBA 11/2011
1	ResistinIBA 04/2011
1	Fatty Acid-Binding ProteinsIBA 03/2011

Therapy/Procedure

1	Caloric Restriction 09/2013